Skip to content
Areas Of Focus

Our startups develop solutions in areas such as:

Artificial intelligence

Using AI, machine learning and machine vision to help health providers make better decisions, as well as safer, more effective treatments.

Diagnostics

New technologies that improve accuracy in medical diagnosis, monitoring and treatment.

Therapeutics

Research and methodologies that accelerate the discovery and development of novel, safe and more effective medicines.

Mental health

Treatments and therapeutics that foster well-being and address substance abuse.

Precision medicine

Customized solutions and therapies that are tailored to individual patients.

Regenerative medicine

Discoveries to replace, engineer or regenerate human cells, tissues and organs.

Our Ecosystem

The MaRS Health ecosystem consists of entrepreneurs, investors, scientists, policy makers, corporates and world-renowned research institutions.

Our team

Ying Tam

Ying Tam

Managing Director, Health Venture Services

Ying Tam is a seasoned entrepreneur and business executive who has co-founded several startup companies. These include Mindful Scientific, a medical device company addressing concussion diagnostics and management that won the startup competition at the Wall Street Journal WSJ.D Live global technology conference and the Medical Device track at the HealthKick Challenge; abridean (acquired by nCipher PLC), a software company that develops application provisioning and identity management solutions; and i-HRx (acquired by HealthConnex), a digital health company focused on chronic disease management. Ying has significant strategic and operational experience since he’s held operating roles in a wide range of organizations, from early-stage companies to major multinational corporations. Previously, he was president and managing director of Maritech Software (acquired by AKVA Group ASA) — an early-stage mid-market ERP software and consulting company — vice president in the Management Consulting Practice at Ernst & Young, and he’s held director level positions at CGI and SAP. Ying began his career at IBM where he held roles in product development, sales and marketing. Ying has a strong track record in mentoring and is heavily involved in the entrepreneurial ecosystem. He has been a mentor for the Entrepreneurship Program at Dalhousie University, for Futurpreneur’s mentorship program, and for Entrepreneur’s Forum. Ying has also spoken at universities and conferences on entrepreneurship and life sciences, and has been entrepreneur-in-residence for the pan-Atlantic Canada startup accelerator. He is currently mentor/advisor to several fledgling startup companies plus aspiring entrepreneurs/businesspeople. Ying has been on the boards of public, private and not-for-profit organizations, and currently serves as director on the boards of WIMTACH and Ogden Pond Technology Group. Ying attended Trinity College at the University of Toronto, where he studied computer science and cognitive psychology.

Richard Bozzato

Richard Bozzato

Senior Advisor, Health

Richard brings over 20 years of experience as a pharmaceutical industry executive, having led the development of innovative drugs, biologics, medical devices and combination products in several therapeutic areas, including metabolic diseases, regenerative medicine, bone repair and orthopaedics, haematology and nicotine addiction. Throughout his career, he has been responsible for overseeing all aspects of the product development process, from basic research, preclinical safety and toxicology, and clinical research to chemistry, manufacturing and regulatory submissions in the United States, Canada and Europe. He has extensive experience in the management of intellectual property, having successfully defended against and challenged competitors’ claims. Highlights

  • Chief Operating Officer at Nicogen Inc.
  • Chief Scientific Officer at ApoPharma Inc, a division of Apotex Inc.
  • Director, Drug Development at Allelix Biopharmaceuticals Inc. (later NPS Pharmaceuticals)
  • Co-founder of the Advanced Regenerative Medicine and Tissue Engineering Consortium
  • Served on the Scientific Advisory Committees of Cangene Corporation and Apotex Research
  • PhD and Honors B.Sc. in Biochemistry from the University of Toronto

Join the innovation community.

Apply to MaRS today.

Learn more